Physician profile
Vijay Rastogi
NPI 1457458648
$5,031.01
in general payments reported to CMS, 2019-2025
43 companies · $1,550 in 2025
The $1,550 reported for 2025 was more than what 95% of Geriatric Medicine (Family Medicine) providers received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $408 · 2020: $288 · 2021: $456 · 2022: $344 · 2023: $742 · 2024: $1,244 · 2025: $1,550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,535.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $718.90 | 2021-2025 | Airsupra, Farxiga, Lokelma |
| Lilly USA, LLC | $573.74 | 2020-2025 | Kisunla, Amyvid, Jardiance |
| Abbvie INC. | $549.77 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $408.45 | 2022-2025 | Verquvo, Capvaxive, Gardasil 9 |
| Bayer Healthcare Pharmaceuticals INC. | $288.84 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $281.69 | 2020-2025 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $271.02 | 2019-2022 | |
| Novo Nordisk INC | $224.17 | 2019-2025 | Rybelsus, Ozempic |
| Pfizer INC. | $218.64 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $145.48 | 2019-2025 | Eliquis, Camzyos |
| Glaxosmithkline, LLC. | $144.66 | 2022-2024 | Arexvy, Trelegy Ellipta |
| Dendreon Pharmaceuticals LLC | $143.82 | 2025 | Provenge |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.34 | 2019-2025 | Ofev, Jardiance, Tradjenta |
| Abbott Laboratories | $82.71 | 2021-2025 | Freestyle Libre 3 |
| Sunovion Pharmaceuticals INC. | $73.51 | 2019 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vijay Rastogi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.